Northern Trust
MNPR icon

Northern Trust’s Monopar Therapeutics MNPR Stock Holding History

Northern Trust’s Portfolio MNPR Stock Details MNPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.21M Buy
34,641
+2,779
+9% +$172K ﹤0.01% 2882
2026
Q1 		$1.75M Buy
31,862
+1,374
+5% +$83K ﹤0.01% 3045
2025
Q4 		$1.99M Buy
30,488
+3,633
+14% +$297K ﹤0.01% 3005
2025
Q3 		$2.19M Sell
26,855
-4,958
-16% -$222K ﹤0.01% 2989
2025
Q2 		$1.14M Buy
31,813
+22,652
+247% +$823K ﹤0.01% 3312
2025
Q1 		$334K Buy
+9,161
New +$330K ﹤0.01% 3747
2023
Q2 		– Sell
-7,410
Closed -$51.5K – 4574
2023
Q1 		$51.5K Buy
7,410
+194
+3% +$2.87K ﹤0.01% 4261
2022
Q4 		$85.5K Sell
7,216
-59
-0.8% -$720 ﹤0.01% 4144
2022
Q3 		$55K Buy
7,275
+234
+3% +$2.22K ﹤0.01% 4298
2022
Q2 		$81K Hold
7,041
– – ﹤0.01% 4251
2022
Q1 		$90K Sell
7,041
-143
-2% -$2.11K ﹤0.01% 4383
2021
Q4 		$115K Sell
7,184
-84
-1% -$1.86K ﹤0.01% 4379
2021
Q3 		$177K Buy
7,268
+47
+0.7% +$1.22K ﹤0.01% 4228
2021
Q2 		$213K Buy
7,221
+21
+0.3% +$601 ﹤0.01% 4142
2021
Q1 		$223K Sell
7,200
-4,559
-39% -$166K ﹤0.01% 4077
2020
Q4 		$360K Sell
11,759
-1,191
-9% -$30.7K ﹤0.01% 3809
2020
Q3 		$347K Buy
12,950
+2,999
+30% +$96.9K ﹤0.01% 3680
2020
Q2 		$372K Buy
+9,951
New +$382K ﹤0.01% 3618

Other funds holding MNPR

JT
Jupiter Topco New York $245B AUM
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Northern Trust's MNPR Position: Q2 2026 in Review

Northern Trust increased its Monopar Therapeutics (MNPR) stake by 8.7% in Q2 2026, buying an estimated $172K and bringing the position to 34,641 shares worth $3.21M. The position accounts for ﹤0.01% of the portfolio, ranked #2882.

Northern Trust first reported a position in MNPR in Q2 2020 and has held it in 18 quarters since. 96 funds tracked by Wall St. Rank hold MNPR as of Q2 2026.

  • Northern Trust held 34,641 shares of Monopar Therapeutics worth $3.21M as of Q2 2026.
  • Northern Trust bought 2,779 Monopar Therapeutics shares in Q2 2026, an estimated $172K.
  • Monopar Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2882 holding.
  • Northern Trust first reported a position in Monopar Therapeutics in Q2 2020 and has held it in 18 quarters since.
  • 96 funds tracked by Wall St. Rank held Monopar Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.